Stock listing

NASDAQ:GRFS Grifols, S.A. Stock

US listing (NASDAQ) of Grifols, S.A. · home listing BME:GRF

Follow Grifols, S.A. into a list and get an email when it puts out news.

Share price · NASDAQ:GRFS

$8.10 USD +0.54 (+7.1%)

Close on Oct 27, 2026

Day range
$7.88 – $8.13 USDOct 27, 2026
Volume
840,515 sharesOct 27, 2026
Market cap
$5.51B USDAt the close on Oct 27, 2026 · price × 680.6M shares outstanding
Grifols, S.A. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
BME:GRF · Home€10.98 EUR+0.30 (+2.8%)2,384,506€10.68€10.98€10.68€10.68Close on Oct 30, 2026
NASDAQ:GRFS$8.10 USD+0.54 (+7.1%)840,515$7.89$8.13$7.88$7.56Close on Oct 27, 2026
BME:GRF.P€7.17 EUR+0.34 (+5.0%)87,926€7.10€7.22€7.10€6.83Close on Oct 27, 2026
OTC:GIKLY$5.55 USD0.00 (0.0%)—$5.55$5.55$5.55$5.55Close on Oct 27, 2026
OTC:GIFLF$10.55 USD0.00 (0.0%)—$10.55$10.55$10.55$10.55Close on Oct 23, 2026
OTC:GIFOF$7.29 USD0.00 (0.0%)—$7.29$7.29$7.29$7.29Close on Oct 27, 2026
Frankfurt:OZTA€10.57 EUR+0.135 (+1.3%)—€10.57€10.57€10.57€10.43Close on Oct 30, 2026
Frankfurt:G0F0€7.09 EUR+0.08 (+1.1%)—€7.09€7.09€7.09€7.01Close on Oct 30, 2026
Frankfurt:G0F€5.05 EUR0.00 (0.0%)—€5.05€5.05€5.05€5.05Close on Oct 30, 2026
Frankfurt:G0FB€7.00 EUR-0.05 (-0.7%)—€7.00€7.00€7.00€7.05Close on Oct 30, 2026
Stuttgart:OZTA€10.68 EUR+0.585 (+5.8%)1,510€10.57€10.76€10.51€10.09Close on Oct 27, 2026
Ticker
NASDAQ:GRFS
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Grifols (Madrid:GRF) Q2 2026 Earnings Call

    Tue, Jul 28, 2026 · 12:30 PM ET

    Watch Transcript

  • Grifols (Madrid:GRF) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 12:30 PM ET

    Watch Transcript

  • Grifols (Madrid:GRF) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 12:30 PM ET

    Watch Transcript

Latest news

Grifols S A signs renewable energy purchase agreement with ENGIE to cover more than half of its electricity consumption in Spain

Sep 16, 2026

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency

Aug 10, 2026

Grifols S A doses first patients in two Phase 3 trials to expand indications of its flagship immunoglobulins

Jul 16, 2026

Grifols S A doses first participant in Phase 3 study evaluating novel subcutaneous therapy for alpha1-antitrypsin deficiency

Jun 29, 2026

Shareholders approve key resolutions at the 2026 Annual General Shareholders’ Meeting

Jun 18, 2026

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

Jun 15, 2026

Grifols: Egypt continues its growth plan through 2029 with an additional investment of €180 million

Jun 12, 2026

Grifols Supports AlphaDetect to Accelerate Detection of Alpha-1

Jun 5, 2026

Grifols S A breaks ground on new manufacturing site in Spain

Jun 3, 2026

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease

Mar 17, 2026

All Grifols, S.A. news

Decks

Grifols, S.A. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
12 in the last 12 months · 21 in all · newest Sep 16, 2026 · oldest 2023
Calls
13 calls with a replay · 13 with a transcript · latest Jul 28, 2026
Decks
29 decks · latest Jul 28, 2026

Where Grifols, S.A. is listed

ListingExchangeCountryCurrency
BME:GRF · Home listingMadridSpainEUR
NASDAQ:GRFS · This pageNASDAQUnited StatesUSD
BME:GRF.PMadridSpainEUR
gettex:OZTAgettexGermanyEUR
Tradegate:OZTATradegateGermanyEUR
OTC:GIKLYOTCUnited StatesUSD
OTC:GIFLFOTCUnited StatesUSD
OTC:GIFOFOTCUnited StatesUSD
LS Exchange:A2ABUQLS ExchangeGermanyEUR
Lang & Schwarz:A2ABUQLang & SchwarzGermanyEUR
Milan:1GRFMilanItalyEUR
BOATS:GRFSBOATSUnited StatesUSD
LS Exchange:A2ABZNLS ExchangeGermanyEUR
EUROTLX:4GRFEUROTLXItalyEUR
Lang & Schwarz:A2ABZNLang & SchwarzGermanyEUR
LSIN:0RDULSINUnited KingdomEUR
LSIN:0RDVLSINUnited KingdomEUR
BMV:GRFPNBMVMexicoMXN
gettex:G0F0gettexGermanyEUR
VIE:GRFViennaAustriaEUR
Aquis:GRFEAquisUnited KingdomEUR
Frankfurt:OZTAFrankfurtGermanyEUR
gettex:G0FgettexGermanyEUR
Tradegate:G0F0TradegateGermanyEUR
Aquis:GRFEAquisUnited KingdomEUR
Aquis:GRFPEAquisUnited KingdomEUR
BMV:GRFNBMVMexicoMXN
Frankfurt:G0F0FrankfurtGermanyEUR
Munich:OZTAMunichGermanyEUR
Aquis:GRFPEAquisUnited KingdomEUR
BIVA:GRFNBIVAMexicoMXN
BIVA:GRFPNBIVAMexicoMXN
BX Swiss:OZTABX SwissSwitzerlandCHF
Dusseldorf:G0FDusseldorfGermanyEUR
Dusseldorf:G0F0DusseldorfGermanyEUR
Dusseldorf:G0FBDusseldorfGermanyEUR
Dusseldorf:OZTADusseldorfGermanyEUR
Frankfurt:G0FFrankfurtGermanyEUR
Frankfurt:G0FBFrankfurtGermanyEUR
gettex:G0FBgettexGermanyEUR
Hamburg:G0F0HamburgGermanyEUR
Hamburg:OZTAHamburgGermanyEUR
Hanover:OZTAHanoverGermanyEUR
Lang & Schwarz:A1C3HHLang & SchwarzGermanyEUR
Lang & Schwarz:A1J1E2Lang & SchwarzGermanyEUR
LS Exchange:A1C3HHLS ExchangeGermanyEUR
LS Exchange:A1J1E2LS ExchangeGermanyEUR
Munich:G0FMunichGermanyEUR
Munich:G0F0MunichGermanyEUR
Munich:G0FBMunichGermanyEUR
Stuttgart:G0F0StuttgartGermanyEUR
Stuttgart:G0FBStuttgartGermanyEUR
Stuttgart:OZTAStuttgartGermanyEUR
Turquoise:GRFETurquoiseUnited KingdomEUR

Log in to ask 6ix AI your own questions about Grifols, S.A.